Exploring the Safety and Efficacy of Direct Oral Anticoagulants (DOACs) in Vulnerable Patient Populations

June 11, 2024

Target Audience

All pharmacists

Learning Objectives

At the completion of this activity, the participant will be able to:

  • Describe the mechanism, dosing, indications, adverse drug reactions of DOACs
  • Evaluate recommendations provided by guidelines including 2023 ACC/AHA/ACCP/HRS Atrial Fibrillation and American Society of Hematology Treatment of VTE or Pulmonary Embolism regarding DOACs usage in vulnerable patient populations
  • Analyze literature utilizing DOACs in individuals with extreme weight, advanced age, or kidney impairment
  • Summarize the safety and efficacy of utilizing DOACs in the vulnerable patient population based on the primary literature
Course summary
Available credit: 
  • 1.00 ACPE
    The Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Course opens: 
06/04/2024
Course expires: 
04/09/2026
Event starts: 
06/11/2024 - 7:00pm EDT
Event ends: 
06/11/2024 - 8:00pm EDT
Cost:
$10.00
Rating: 
0
ZOOM or Brooklyn Hospital
United States

Pauletta Lazarevskiy, PGY-1 Pharmacy Resident, PharmD.

Pauletta Lazarevskiy graduated from the Arnold and Marie Schwartz College of Pharmacy and Health Sciences at Long Island University in 2023 and is a PGY1 pharmacy resident at The Brooklyn Hospital Center. Starting this July, she will begin her Ambulatory Care PGY-2 at The Brooklyn Hospital Center.

 

ACPE UAN 0042-0000-24-036-L01-P

Available Credit

  • 1.00 ACPE
    The Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Price

Cost:
$10.00
Please login or register to take this course.

Required Hardware/software

You will need a device that allows you to hear and see the presentation. Some phones may have limited functionality.